vimarsana.com

Latest Breaking News On - Intellectual property advisor - Page 1 : vimarsana.com

US Patent and Trademark Office keen to help Guyana with Intellectual Property; Guyana s outdated IP laws disincentivise investments – Demerara Waves Online News- Guyana

US Patent and Trademark Office keen to help Guyana with Intellectual Property; Guyana s outdated IP laws disincentivise investments – Demerara Waves Online News- Guyana
demerarawaves.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from demerarawaves.com Daily Mail and Mail on Sunday newspapers.

Fractus Expands Licensing Program into the Heart of Medical Device Tech

BARCELONA, Spain, Jan. 22, 2024 /PRNewswire/ Fractus, renowned for pioneering advancements in antenna technology, proudly announces the successful licensing of its technology for wireless implantable devices like pacemakers, defibrillators and resynchronization devices.     

Investorideas com - Investor Ideas Potcasts #510, Cannabis News and Stocks on the Move (TSX: WEED) (NASDAQ: CGC) (TSX: RIV) (CSE: HOLL) (TSX: VFF)

Investorideas com - Investor Ideas Potcasts #510, Cannabis News and Stocks on the Move (TSX: WEED) (NASDAQ: CGC) (TSX: RIV) (CSE: HOLL) (TSX: VFF)
investorideas.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investorideas.com Daily Mail and Mail on Sunday newspapers.

MagicMed Industries Announces the Establishment of Psilocybin-Derivatives Portfolio and Launch of Candidate Selection Program

 MagicMed Industries Inc. (CSE: MGIC reserved) ( MagicMed or the Company ) announced today that it has completed the establishment of the psilocybin-derivatives patent portfolio of the Psybrary TM and the launch of the Candidate Selection program.  The Psybrary TM is a proprietary physical and knowledgebase collection of novel psychedelic-derivative drug candidates, manufacturing methods, pharmacological data, and patent filings that protect all of the above. MagicMed s Chief Scientific Officer, Dr. Peter Facchini, stated Our psilocybin-derivatives portfolio, which also captures dimethyltryptamine (DMT) derivatives, now includes 12 filed patent applications directed to 9 different chemical compound categories covering over 125 million individual molecules.  While we certainly don t expect to synthesize all of these molecules during the development of new drug candidates, I am pleased to announce that, as of today s launch of the Candidate Selection program, we have alre

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.